SVWAG
REGN icon

Sound View Wealth Advisors Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Sound View Wealth Advisors Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.89M Buy
2,445
+14
+0.6% +$10.7K 0.13% 133
2025
Q4 		$1.88M Buy
2,431
+28
+1% +$19K 0.13% 130
2025
Q3 		$1.35M Sell
2,403
-40
-2% -$22.6K 0.09% 165
2025
Q2 		$1.28M Buy
2,443
+214
+10% +$119K 0.09% 167
2025
Q1 		$1.41M Buy
2,229
+2
+0.1% +$1.38K 0.12% 145
2024
Q4 		$1.59M Buy
2,227
+183
+9% +$154K 0.13% 136
2024
Q3 		$2.15M Buy
2,044
+83
+4% +$92.4K 0.18% 120
2024
Q2 		$2.06M Sell
1,961
-193
-9% -$187K 0.21% 108
2024
Q1 		$2.07M Sell
2,154
-38
-2% -$36.1K 0.22% 107
2023
Q4 		$1.93M Buy
2,192
+10
+0.5% +$8.23K 0.21% 114
2023
Q3 		$1.8M Buy
2,182
+75
+4% +$58.9K 0.22% 99
2023
Q2 		$1.51M Buy
2,107
+34
+2% +$26.2K 0.2% 110
2023
Q1 		$1.7M Sell
2,073
-119
-5% -$89.8K 0.23% 95
2022
Q4 		$1.93M Buy
2,192
+210
+11% +$155K 0.21% 114
2022
Q3 		$1.36M Buy
1,982
+62
+3% +$39K 0.31% 82
2022
Q2 		$1.14M Sell
1,920
-1
-0.1% -$650 0.24% 104
2022
Q1 		$1.34M Sell
1,921
-32
-2% -$20.2K 0.26% 97
2021
Q4 		$1.23M Sell
1,953
-2
-0.1% -$1.23K 0.23% 105
2021
Q3 		$1.18M Buy
1,955
+2
+0.1% +$1.24K 0.25% 102
2021
Q2 		$1.09M Buy
1,953
+20
+1% +$10.1K 0.23% 107
2021
Q1 		$915K Sell
1,933
-23
-1% -$11.2K 0.21% 108
2020
Q4 		$945K Buy
1,956
+4
+0.2% +$2.16K 0.23% 104
2020
Q3 		$1.09M Sell
1,952
-25
-1% -$15.2K 0.29% 91
2020
Q2 		$1.23M Sell
1,977
-132
-6% -$74.9K 0.35% 84
2020
Q1 		$1.03M Sell
2,109
-61
-3% -$25.2K 0.36% 80
2019
Q4 		$815K Sell
2,170
-24
-1% -$8.07K 0.23% 105
2019
Q3 		$609K Sell
2,194
-33
-1% -$9.77K 0.18% 124
2019
Q2 		$697K Buy
+2,227
New +$741K 0.21% 119

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Sound View Wealth Advisors Group's REGN Position: Q1 2026 in Review

Sound View Wealth Advisors Group increased its Regeneron Pharmaceuticals (REGN) stake by 0.58% in Q1 2026, buying an estimated $10.7K and bringing the position to 2,445 shares worth $1.89M. The position accounts for 0.13% of the portfolio, ranked #133.

Sound View Wealth Advisors Group first reported a position in REGN in Q2 2019 and has held it in 28 quarters since. The position peaked at $2.15M in Q3 2024. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Sound View Wealth Advisors Group held 2,445 shares of Regeneron Pharmaceuticals worth $1.89M as of Q1 2026.
  • Sound View Wealth Advisors Group bought 14 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $10.7K.
  • Regeneron Pharmaceuticals made up 0.13% of Sound View Wealth Advisors Group's portfolio in Q1 2026, its #133 holding.
  • Sound View Wealth Advisors Group first reported a position in Regeneron Pharmaceuticals in Q2 2019 and has held it in 28 quarters since.
  • Sound View Wealth Advisors Group's Regeneron Pharmaceuticals position peaked at $2.15M in Q3 2024.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Sound View Wealth Advisors Group's 13F filing for Q1 2026, filed 6 May 2026.